Home›Screener›MRNA›Profile
C
53/100

Moderna Inc

MRNAmRNA Therapeutics
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Moderna Inc (MRNA) is the lead sponsor of 31 active clinical trials listed on ClinicalTrials.gov[5], including 4 Phase 3[1], 15 Phase 2[2], 17 Phase 1[3], 3 Phase 4[4].

Trial NCT07117487[6] evaluates mRNA-1345 in Respiratory Syncytial Virus with a target enrollment of 507 participants. Trial NCT06592794[7] evaluates mRNA-1403 in Acute Gastroenteritis with a target enrollment of 37864 participants. Trial NCT06067230[8] evaluates mRNA-1345 in Respiratory Syncytial Virus with a target enrollment of 1153 participants.

MRNA has 1 Form 4 insider filing recorded at the SEC in the past 30 days[9].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. ClinicalTrials.gov (2026-04-11) ↗
  5. ClinicalTrials.gov (2026-04-11) ↗
  6. ClinicalTrials.gov · NCT07117487 (2026-01-30) ↗
  7. ClinicalTrials.gov · NCT06592794 (2026-02-25) ↗
  8. ClinicalTrials.gov · NCT06067230 (2025-08-08) ↗
  9. SEC EDGAR · 0001682852 (2026-04-11) ↗
🏛
Upcoming Catalysts
mRNA-1283 — RSV vaccine adult
2026-07-08
in 34d
mResvia (mRNA-1345) — RSV older adults sNDA
2027-05-12
in 342d
🔬
Clinical Trials
31
NCT03313778Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03897881Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04159103Propionic Acidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04899310Methylmalonic Acidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05095727Glycogen Storage Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05130437Propionic Acidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05164094Epstein-Barr Virus Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05295433Methylmalonic Acidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05533697Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05575492Cytomegalovirus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05683457Cytomegalovirus Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05701800Herpes Zoster
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05743881Respiratory Syncytial Virus, Human Metapneumovirus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05769621Propionic Acidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05831111Epstein-Barr Virus Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05992935Norovirus Acute Gastroenteritis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06067230Respiratory Syncytial Virus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06143046Respiratory Syncytial Virus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06189053Myocarditis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06333704SARS-CoV-2
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06585241SARS-CoV-2
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06592794Acute Gastroenteritis, Norovirus Acute Gastroenteritis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06655870Healthy Participants
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06735248Multiple Sclerosis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06880549Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07089706COVID-19
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07116616Relapsed or Refractory Multiple Myeloma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07117487Respiratory Syncytial Virus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07266558SARS-CoV-2
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07478952Epstein-Barr Virus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07496450Influenza
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
1 filing
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates2
Insider Filings1
Clinical Trials5
Sector Peers (mRNA Therapeutics)
TBIOTranslate Bio
D
BNTXBioNTech SE
F
Data Provenance
cik1 verified
clinical trial31 verified
insider buy1 verified
trial count5 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR